CONSORT 2025 statement: updated guideline for reporting randomised trials

Oxford BioMedica (United Kingdom), University of Toronto, Women's College Hospital, University of Oxford, University of Southern Denmark, Odense University Hospital, Cochrane, Ottawa Hospital, Ottawa Hospital Research Institute, University of North Carolina at Chapel Hill, Jawaharlal Institute of Post Graduate Medical Education and Research, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, Rutgers, The State University of New Jersey, Open Invention Network (United States), Society for Applied Studies, Hospital for Sick Children, University of Aberdeen, Miami University, London School of Hygiene & Tropical Medicine, Northwestern University, Stanford University, Bond University, Protein Metrics (United States), MRC Clinical Trials Unit at UCL, University College London, Great Ormond Street Hospital, University of Exeter, NIHR Exeter Clinical Research Facility, University of Edinburgh, Harvard University, Inserm, Université Paris Cité, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Sorbonne Paris Cité, Centre de Recherche Épidémiologie et Statistique, Robarts Clinical Trials, Clinical Research Institute, Duke Medical Center, University of California, Los Angeles, South African Medical Research Council, University of Warwick, MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Impact, St. Joseph’s Healthcare Hamilton, McMaster University, University of York, University of Alberta, Sorbonne Université, Université Sorbonne Paris Nord, Assistance Publique – Hôpitaux de Paris, Hôtel-Dieu de Paris